NCT02759354

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year-Old Children Previously Vaccinated With a 2-Dose or 3-Dose Infants Series and Toddler Dose With Vaxelis® or INFANRIX® Hexa

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 754 (actual)
• Sponsor: MCM Vaccines B.V. · Industry
• Sex: All
• Age: 3 Years – 5 Years
• Healthy volunteers: Accepted

Summary

This is a multicenter extension study of two European randomized, double-blind studies (V419-007 and V419-008). It describes long-term persistence of hepatitis B and pertussis antibody responses in healthy 4- to 5 year old children previously vaccinated with Vaxelis® or INFANRIX® hexa

Conditions

• Hepatitis B
• Pertussis

Interventions

Type	Name	Description
OTHER	Blood Sample	Blood sample at approx. 4 years of age

Timeline

• Start date: 2016-04-26
• Primary completion: 2016-07-29
• Completion: 2016-08-01
• First posted: 2016-05-03
• Last updated: 2020-06-09
• Results posted: 2019-06-27